+1 (888) 794-0077
X
X
Contact Us
Solutions
IND-Enabling
NDA-Enabling
Small Molecule
Large Molecule
New Modalities
Oligonucleotide Solutions
Antibody-Drug Conjugates
Peptides
Protein Degrader Solutions
CAR-T
mRNA
Talk to an Expert
Testing Services
Bioanalysis
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Discovery
Preclinical
Clinical
Biomarkers
Bioanalytical Methods
Central Lab Services
DMPK
In Vitro ADME
Metabolic Stability
Drug-Drug Interaction
Kinetic & Thermodynamic Solubility
Plasma Protein Binding
Rodent PK
Large Animal PK
Non-GLP Bioanalysis
Metabolite Profiling & ID
Non-Clinical Mass Balance & Tissue Distribution
Human Radiolabel-AME
Radiolabeled In Vivo PK/ADME Studies
Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
In Vitro Toxicology
Developmental & Reproductive Toxicology
Carcinogenicity Testing Services
Ophthalmology
Preclinical Development of Biologics
Preclinical Immunology
Vaccine Development
Standard for Exchange of Nonclinical Data (SEND)
Preclinical Pathology
Repeat Dose Toxicity
Dose Ranging & MTD Studies
Single Dose Acute Toxicity Testing
Molecular Imaging Services
Company
WuXi AppTec Lab Testing Leadership Team
Global Facilities & Compliance
Contact Us
Insights
Blog
Digital Learning
Trade Articles
Events
Meet Our Experts
Select Page
Xiaoxia Li
Categories
COVID-19
Preclinical Safety
Preclinical Testing
Regulatory
Regulatory Expertise
Technical Expertise
Recent Posts
Moving From GLP-1 to Multi-Target Metabolic Medicines
Five Ways PROTACs Break From ADME Norms
Beyond Single-Marker Pathology: How Highly Multiplex Fluorescence Imaging Is Expanding Translational Research
ELISA v LC-MS/MS: Preclinical Bioanalysis Platforms for ADCs in Focus
How Biomarker Testing Services Support Precision Medicine Programs
